350 related articles for article (PubMed ID: 16051732)
1. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
Weiss J; Sauer A; Frank A; Unger M
Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.
Mathews JM; Etheridge AS; Valentine JL; Black SR; Coleman DP; Patel P; So J; Burka LT
Drug Metab Dispos; 2005 Oct; 33(10):1555-63. PubMed ID: 16033948
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
Uebelhack R; Franke L; Schewe HJ
Pharmacopsychiatry; 1998 Sep; 31(5):187-92. PubMed ID: 9832350
[TBL] [Abstract][Full Text] [Related]
4. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
[TBL] [Abstract][Full Text] [Related]
5. In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones.
Melchert PW; Qian Y; Zhang Q; Klee BO; Xing C; Markowitz JS
Chem Biol Interact; 2022 Apr; 357():109883. PubMed ID: 35278473
[TBL] [Abstract][Full Text] [Related]
6. Kava does not display metabolic toxicity in a homogeneous cellular assay.
Zou L; Harkey MR; Henderson GL; Dike LE
Planta Med; 2004 Apr; 70(4):289-92. PubMed ID: 15095141
[TBL] [Abstract][Full Text] [Related]
7. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
[TBL] [Abstract][Full Text] [Related]
8. Kavalactones fail to inhibit alcohol dehydrogenase in vitro.
Anke J; Fu S; Ramzan I
Phytomedicine; 2006 Feb; 13(3):192-5. PubMed ID: 16428028
[TBL] [Abstract][Full Text] [Related]
9. Monoamine Oxidase Inhibition by Kavalactones from Kava (Piper Methysticum).
Prinsloo D; van Dyk S; Petzer A; Petzer JP
Planta Med; 2019 Oct; 85(14-15):1136-1142. PubMed ID: 31539917
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
Feltenstein MW; Lambdin LC; Ganzera M; Ranjith H; Dharmaratne W; Nanayakkara NP; Khan IA; Sufka KJ
Phytother Res; 2003 Mar; 17(3):210-6. PubMed ID: 12672148
[TBL] [Abstract][Full Text] [Related]
11. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
Tang Y; Fields C
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
Anke J; Ramzan I
J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm.
Smith KK; Dharmaratne HR; Feltenstein MW; Broom SL; Roach JT; Nanayakkara NP; Khan IA; Sufka KJ
Psychopharmacology (Berl); 2001 Apr; 155(1):86-90. PubMed ID: 11374340
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ
Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328
[TBL] [Abstract][Full Text] [Related]
16. Densitometric analysis of kawain in kava-kava root extracts.
Janeczko Z; Krzek J; Pilewski N; Walusiak D
Acta Pol Pharm; 2001; 58(6):463-8. PubMed ID: 12197620
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers.
Kanumuri SRR; Mamallapalli J; Nelson R; McCurdy CR; Mathews CA; Xing C; Sharma A
J Ethnopharmacol; 2022 Oct; 297():115514. PubMed ID: 35777607
[TBL] [Abstract][Full Text] [Related]
18. Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23.
Ma Y; Sachdeva K; Liu J; Ford M; Yang D; Khan IA; Chichester CO; Yan B
Drug Metab Dispos; 2004 Nov; 32(11):1317-24. PubMed ID: 15282211
[TBL] [Abstract][Full Text] [Related]
19. Isolation and Purification of Potent Growth Inhibitors from
Van TM; Xuan TD; Minh TN; Quan NV
Molecules; 2018 Jul; 23(8):. PubMed ID: 30065174
[No Abstract] [Full Text] [Related]
20. [Kava-kava preparations--alternative anxiolytics].
Nowakowska E; Ostrowicz A; Chodera A
Pol Merkur Lekarski; 1998 Mar; 4(21):179-180a. PubMed ID: 9640076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
